Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing cetuximab in combination with chemotherapy as first-line therapy for metastatic colorectal cancer has completed. The update summarizes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED